Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of ...

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

【6月17日再生元制药拒对23andMe提新收购要约】 6月17日，再生元制药公司发言人透露，公司已拒绝为基因检测公司23andMe提出高于2.56亿美元的新收购要约。在破产拍卖中，23andMe联合创始人Anne ...

A nonprofit run by Anne Wojcicki, the cofounder and former CEO of 23andme, has agreed to buy the genetic testing company for ...

A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.

"There are only a handful of people in the world who have experience in running a direct-to-consumer genetic testing company ...

The fate of 23andMe (MEHCQ) and the treasure trove of data it has on its users is set to be fought over in court. Yahoo ...

23andme曾于2021年高价收购远程医疗平台Lemonaid，本来业务就持续亏损，2023年还爆发近700万用户的基因数据被泄露事故，导致23andMe陷入了信任危机，集体诉讼接连不断，创始人安妮·沃西基多次提出私有化方案，意图公司重回自己手中， ...

Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second ...

Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.